Guidance
Skip Standards and indicators submenu
Quality standards
Our quality standards set out priority areas for quality improvement. They highlight areas with identified variation in current practice.
View our quality standards
How to use our quality standards
The timeline for developing quality standards
Help us develop quality standards
Selecting and prioritising quality standards topics
About quality standards
Indicators
Our indicators measure outcomes that reflect the quality of care, or processes linked by evidence to improved outcomes.
View list of indicators
Learn about the committee that develops indicators
About indicators
Skip Life sciences submenu
Life Sciences
We offer tailored support to industry during product development. Our expertise can help you build the evidence needed to achieve market access.
View life sciences
Get support from NICE
NICE Advice service
Trusted, unrivalled expertise.
Make an enquiry
Contact us to discuss your requirements.
Innovative Licensing and Access Pathway (ILAP)
Streamlining patient access to safe, financially sustainable and innovative medicines.
Learn how we evaluate technologies
Health technology evaluation and topic selection manuals
Updated manuals for methods, processes and topic selection.
Digital health technologies
Accelerating our efforts to deliver innovation to the health and care system.
Evidence standards framework
Using the best available evidence to develop recommendations that guide decisions in health, public health and social care.
Our guidance programmes
Ensuring new technologies are clinically effective and offer economic value.
Register your product
Non-pharmaceutical
NHS Innovation Service is a clear and simple point of entry for health technologies to access support and national evaluation programmes.
Pharmaceutical
UK PharmaScan is a database of new medicines, indications and formulations in the pharmaceutical pipeline.
Find published and proposed evaluations
Diagnostics
Guidance on measurements and tests used to evaluate a patient's condition.
Medical technologies
Guidance on medical technologies put forward to NICE by manufacturers.
Technology appraisals
Guidance on new and existing medicines and treatments in the NHS.
Highly specialised technologies
Guidance on the use of highly specialised medicines and treatments.
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
Skip About submenu
About
NICE helps practitioners and commissioners get the best care to patients, fast, while ensuring value for the taxpayer.
Explore about
Our programmes
Learn about the information we produce.
Guidance
Advice
Quality standards
Indicators
Digital health
Topic selection
Get involved
Understand how decisions are made:
Attend a committee meeting
Comment on draft guidance:
Guidance in consultation
Be part of a guidance committee:
Join a committee
Help develop our products:
Register as a stakeholder
Putting you at the heart of our work:
Public involvement
What we do
Social care
Life sciences
NICE international
Patient safety
Shared decision making
Into practice
Social care quick guides
Measuring the use of NICE guidance
Resource planner
View all Into practice
Who we are
The board
The NICE strategy 2021 to 2026
Corporate publications
View all Who we are
- Contact us
- Jobs

Alcohol-use disorders: diagnosis and management of physical complications

Clinical guideline
Reference number: CG100
Published: 02 June 2010
Last updated: 12 April 2017

Alcohol use disorders - clinical management: scope consultation

NICE were asked to develop a clinical practice guideline on The management of alcohol use disorders in adults and adolescents for use in the NHS in England and Wales. Consultation on the draft scope ended on 2 May 2008.

Consultation on draft guideline: 28 August - 23 October 2009

Anticipated publication date: March 2010

Further information

More information on NICE's guideline development process

This page was last updated: 30 March 2010

CG100 Alcohol-use disorders - diagnosis and clinical management of alcohol-related physical complications: review proposal (PDF 466 KB)

Published:

06 March 2015
CG100 Alcohol-use disorders - diagnosis and clinical management of alcohol-related physical complications: list of registered stakeholders March 2015 (PDF 48 KB)

Published:

06 March 2015
CG100 Alcohol-use disorders - diagnosis and clinical management of alcohol-related physical complications: surveillance review decision CG100 and CG115 alcohol use disorders April 2015 (PDF 772 KB)

Published:

13 April 2015
CG100 Alcohol-use disorders - physical complications: evidence update (PDF 315 KB)

Published:

01 March 2012
Alcohol use disorders - clinical management: scope consultation comments (PDF 132 KB)

Published:

04 July 2008
Alcohol use disorders - clinical management: final scope (PDF 45 KB)

Published:

04 July 2008
Alcohol use disorders: GDG members (PDF 65 KB)

Published:

07 July 2009
Alcohol use disorders: minutes of GDG meeting 8 - 10 March 2009 (PDF 43 KB)

Published:

28 July 2009
Alcohol use disorders: minutes of GDG meeting 9 - 21 April 2009 (PDF 45 KB)

Published:

28 July 2009
Alcohol use disorders: minutes of GDG meeting 10 - 19 May 2009 (PDF 46 KB)

Published:

28 July 2009
Alcohol use disorders: minutes of GDG meeting 11 - 16 June 2009 (PDF 47 KB)

Published:

28 July 2009
Alcohol use disorders - clinical management: full guideline for consultation (PDF 1.82 MB)

Published:

17 September 2009
Corticosteroid treatment for alcohol-related hepatitis (PDF 152 KB)

Published:

17 September 2009
Diagnosis of chronic pancreatitis (PDF 31 KB)

Published:

17 September 2009
Enzyme supplementation (PDF 126 KB)

Published:

17 September 2009
Indications for admission to hospital care (PDF 140 KB)

Published:

17 September 2009
Indications for admission to hospital care - health economics (PDF 95 KB)

Published:

17 September 2009
Liver transplant (PDF 33 KB)

Published:

17 September 2009
Liver transplant - health economics (PDF 109 KB)

Published:

17 September 2009
Nutritional support for acute alcohol-related pancreatitis (PDF 153 KB)

Published:

17 September 2009
Nutritional support in alcohol-related liver disease (PDF 52 KB)

Published:

17 September 2009
Pancreatic surgery (PDF 81 KB)

Published:

17 September 2009
Prophylactic antibiotic treatment in acute pancreatitis (PDF 77 KB)

Published:

17 September 2009
Role of liver biopsy - accuracy (PDF 40 KB)

Published:

17 September 2009
Role of liver biopsy - safety (PDF 124 KB)

Published:

17 September 2009
Supportive care (PDF 76 KB)

Published:

17 September 2009
Treatment for withdrawal (PDF 42 KB)

Published:

17 September 2009
Wernicke's encephalopathy (PDF 114 KB)

Published:

17 September 2009
Acute alcohol withdrawal algorithm (PDF 14 KB)

Published:

17 September 2009
Alcohol-related liver disease algorithm (PDF 38 KB)

Published:

17 September 2009
Alcohol use disorders - clinical management: NICE version for consultation (PDF 103 KB)

Published:

17 September 2009
Alcohol use disorders - clinical management: consultation comments proforma (MSWord 50 KB)

Published:

14 September 2009
Alcohol use disorders - clinical management: list of stakeholders (PDF 33 KB)

Published:

07 May 2010
Alcohol use disorders - clinical management: pre publication check error table (PDF 26 KB)

Published:

02 June 2010
Alcohol use disorders - clinical management: full guidelines (PDF 2.72 MB)

Published:

22 February 2010
Alcohol use disorders - clinical management: consultation comments table (PDF 890 KB)

Published:

22 February 2010